Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Liberatore

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmaceutics|November 27, 2021
In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal AntibodiesSilvere Pagant, Rachel A Liberatore
Immunity|July 23, 2011
Sensing retrovirusesRachel A Liberatore, Paul D Bieniasz
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivoRachel A Liberatore, Paul D Bieniasz
International Immunology|February 21, 2009
c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activationRachel A Liberatore, Stephen P Goff
Immunity|March 21, 2019
The Miami Monkey: A Sunny Alternative to the Berlin PatientRachel A Liberatore, David D Ho
Pharmaceutics|April 27, 2024
Delivery of DNA-Based Therapeutics for Treatment of Chronic DiseasesCarleigh Sussman, Rachel A Liberatore, Marek M Drozdz
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
NF-kappaB activity is constitutively elevated in c-Abl null fibroblastsRachel A Liberatore, Stephen P Goff, Irene Nunes
Plos Pathogens|July 18, 2020
Inhibition of spumavirus gene expression by PHF11Melissa Kane, Vincent Mele, Rachel A Liberatore, et al.
Journal of Virology|April 7, 2017
Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus PathogenesisRachel A Liberatore, Emily J Mastrocola, Chelsea Powell, et al.
Emerging Microbes & Infections|June 25, 2020
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodiesChasity D Andrews, Yaoxing Huang, David D Ho, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmaceutics|November 27, 2021
In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal AntibodiesSilvere Pagant, Rachel A Liberatore
Immunity|July 23, 2011
Sensing retrovirusesRachel A Liberatore, Paul D Bieniasz
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivoRachel A Liberatore, Paul D Bieniasz
International Immunology|February 21, 2009
c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activationRachel A Liberatore, Stephen P Goff
Immunity|March 21, 2019
The Miami Monkey: A Sunny Alternative to the Berlin PatientRachel A Liberatore, David D Ho
Pharmaceutics|April 27, 2024
Delivery of DNA-Based Therapeutics for Treatment of Chronic DiseasesCarleigh Sussman, Rachel A Liberatore, Marek M Drozdz
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
NF-kappaB activity is constitutively elevated in c-Abl null fibroblastsRachel A Liberatore, Stephen P Goff, Irene Nunes
Plos Pathogens|July 18, 2020
Inhibition of spumavirus gene expression by PHF11Melissa Kane, Vincent Mele, Rachel A Liberatore, et al.
Journal of Virology|April 7, 2017
Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus PathogenesisRachel A Liberatore, Emily J Mastrocola, Chelsea Powell, et al.
Emerging Microbes & Infections|June 25, 2020
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodiesChasity D Andrews, Yaoxing Huang, David D Ho, et al.
Pageof 2